SLC7A11 and glioblastoma: It has been reported that mTOR activation increases SLC7A11 protein levels by suppressing lysosomal degradation in glioblastoma cells, and inhibition with Torin 1 reduced the protein levels of SLC7A11 (Yamaguchi et al. 2020).